As you will be aware The Department for Health and Social Care has asked NICE to conduct an appraisal of Daridorexant for treating insomnia [ID3774].
Please note that following conversations between NICE and the company, the timelines for this appraisal have been revised and the appraisal is now anticipated to begin during late April 2022 when we will write to you about how you can get involved.